InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
17,060.40
(
0.00%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.51
(
0.33%
)
Bitcoin
64,067.56
(
-0.33%
)
Post# of 177066
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jedijazz

Send PM Follow Ignore
Followers 1321
Posts 246871
Boards Moderated 52
Alias Born 12/07/2009

jedijazz

Member Level

Re: None

Thursday, 09/22/2022 1:38:53 PM

Thursday, September 22, 2022 1:38:53 PM

Post# of 177066
$NMRD "Company sits at the intersection of the global Type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023."

For more information, please visit www.NemauraMedical.com

In the Most recent news, CEO Dr. Faz Chowdhury presented a corporate overview at the 24th Annual H.C. Wainwright Global Investment Conference, which was held on September 12 – 14, 2022.
https://www.nasdaq.com/press-release/nemaura-medical-to-present-at-the-24th-annual-h.c.-wainwright-global-investment


ALL comments are In My Own OPINION. Please Use Your Own DD for Stock Trading.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up